Complementary and alternative medicine among Singapore cancer patients

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 2, 2010, Pages 129-135

  Chow, Wen Hann ^a   Chang, Pearlly ^a   Lee, Soo Chin ^b   Wong, Alvin ^b   Shen, Han Ming ^a   Verkooijen, Helena Marieke ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Oncology; Patients' expectations; Quality of life; Survey

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUPUNCTURE; ADULT; AGE DISTRIBUTION; AGED; ALLOPATHY; ALTERNATIVE MEDICINE; ARTICLE; ASSOCIATION; AWARENESS; AYURVEDA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; CHINESE; CHINESE MEDICINE; DOCTOR PATIENT RELATION; EDUCATION; ETHNICITY; EXPECTATION; FEMALE; HEALTH BEHAVIOR; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MASSAGE; MEDICAL INFORMATION; MEDITATION; MOXIBUSTION; NEOPLASM; PATIENT ASSESSMENT; PATIENT ATTITUDE; PHYSICIAN; PREDICTOR VARIABLE; PROFESSIONAL KNOWLEDGE; QUALITY OF LIFE; QUESTIONNAIRE; REFLEXOLOGY; SINGAPORE; SUPPLEMENTATION; UNIVERSITY HOSPITAL; YOGA;

EID: 77949533702     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, et al The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol 2005;44:161-7.
2. Kim MJ, Lee SD, Kim DR, Kong YH, Sohn W S, Ki SS, et al. Use of complementary and alternative medicine among Korean cancer patients. Korean J Intern Med 2004;19:250-6.
3. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005;23:2645-54.
4. van der Weg F, Streuli R A. Use of alternative medicine by patients with cancer in a rural area of Switzerland. Swiss Med Wkly 2003;133:233-40.
5. Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005;13:806-11.
6. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005;16:655-63.
7. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
8. Hana G, Bar-Sela G, Zhana D, Mashiach T, Robinson E. The use of complementary and alternative therapies by cancer patients in northern Israel. Isr Med Assoc J 2005;7:243-7.
9. Risberg T, Kaasa S, Wist E, Melsom H. Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 1997;33:575-80.
10. Gupta D, Lis CG, Birdsall TC, Grutsch JF. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer 2005;13:912-9.
11. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 2004;12:454-62.
12. Lee AH, Ingraham SE, Kopp M, Foraida MI, Jazieh AR. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Am J Clin Oncol 2006;29:178-82.
13. Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007;7:4.
14. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
15. Nemeth G. Health related quality of life outcome instruments. Eur Spine J 2006;15Suppl1:S44-51.
16. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43.
17. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005;27:1847-58.
18. Lim MK, Sadarangani P, Chan HL, Heng JY. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med 2005;13:16-24.
19. Davis GE, Bryson CL, Yueh B, McDonell MB, Micek MA, Fihn SD. Treatment delay associated with alternative medicine use among veterans with head and neck cancer. Head Neck 2006;28:926-31.
20. Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol 2007;25:548-54.
21. Ernst E. Regulating complementary medicine. Only 0.08% of funding for research in NHS goes to complementary medicine. BMJ 1996;313:882.
22. Lee MY, Benn R, Wimsatt L, Cornman J, Hedgecock J, Gerik S, et al. Integrating complementary and alternative medicine instruction into health professions education: organizational and instructional strategies. Acad Med 2007;82:939-45.